A decade of cell therapy clinical trials (2000–2010)

Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge™ era

(2012) Philip M Arlen et al.   Expert Review of Vaccines

Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive

(2012) Romaldas Maciulaitis et al.   MOLECULAR THERAPY

Hemacord approval may foreshadow regulatory creep for HSC therapies

(2012) Malorye Allison   NATURE BIOTECHNOLOGY

The ClinicalTrials.gov Results Database

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

The ClinicalTrials.gov Results Database — Update and Key Issues

(2011) Deborah A. Zarin et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Quality of Registration of Clinical Trials

(2011) Roderik F. Viergever et al.   PLoS One

Cell therapy industry: billion dollar global business with unlimited potential

(2011) Chris Mason et al.   Regenerative Medicine

In vitro generation of red blood cells for transfusion: a model for regenerative medicine

(2011) Luc Douay   Regenerative Medicine

Unseen World of Clinical Trials Emerges From U.S. Database

(2011) E. Marshall   SCIENCE

Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs

(2010) J A DiMasi et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

(2010) K I Kaitin et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Registering Clinical Trial Results

(2010) James Dabney Miller   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Translation Cycle: round and round in cycles is the only way forward for regenerative medicine

(2010) Chris Mason et al.   Regenerative Medicine

Regenerative medicine cell therapies: numbers of units manufactured and patients treated between 1988 and 2010

(2010) Chris Mason et al.   Regenerative Medicine

Trial Publication after Registration in ClinicalTrials.Gov: A Cross-Sectional Analysis

(2009) Joseph S. Ross et al.   PLOS MEDICINE